Home Company Team Technology Products Investors Contact Us





Ohmx has completed the development of a Class I device under ISO 13485 compliance, and is working towards a CE Mark for its alpha system. The Ohmx platform has been validated to show superior analytical performance to predicate devices, and validation has been completed using patient samples for more than 10 clinical analytes.

Ohmx has established its Quality Management System and is interfacing with regulatory consultants, product subcontractors and manufacturers in preparation of its regulatory submissions.

Core to Ohmx’s technology is its IP portfolio, which began with licenses for 41 patents developed by its founder, Northwestern University Professor Thomas Meade, PhD. Ohmx has recently had 10 patent applications granted and two allowed. For more information on Ohmx IP, please visit the Intellectual Property page.

Ohmx is in active discussions with potential strategic partners interested in collaborative research, co-development and licensing agreements. For more information, please contact: info@ohmx.com


[ back to top ]

Design by Digizyme